In barely a decade, RNA-mediated interference (RNAi) has evolved from a fascinating biological phenomenon into a powerful experimental tool. Progress in genome sequencing and annotation, as well ...
The ability to trigger RNA interference in mammalian cells provides unprecedented opportunities for probing the functions of genes. Many products and resources are there to help. Laura Bonetta ...
Rebecca Roberts is a science writer and communicator. She earned her PhD in molecular biology from the University of the Sunshine Coast in Australia and completed a two-year postdoctoral fellowship at ...
The technique: A specific short peptide aimed at fat cells can deliver a DNA sequence that knocks down expression of a key fatty acid binding protein. Mice on a high-fat diet treated with this ...
Alnylam's RNAi TTR Silencing Drug Amvuttra FDA Approved for Transthyretin Amyloidosis Cardiomyopathy
The drug was already sold for TTR amyloidosis with polyneuropathy, and now is available to patients with hereditary or wild-type ATTR-CM.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback